| ADLAI NORTYE LTD. SP.ADR |
| USA |
| Gesundheit |
| US00704R1095 / A3EEED |
| N2U0 (Frankfurt) / ANL (NASDAQ) |
| FRA:N2U0, ETR:N2U0, N2U0:GR, NASDAQ:ANL |
| - |
| https://www.adlainortye.c.. |
|
Adlai Nortye Ltd. ADR is an American Depositary Receipt representing shares of Adlai Nortye Ltd., a biopharmaceutical company. The primary purpose of this ADR is to provide U.S. investors with a convenient way to invest in a Chinese company, allowing..
>Volltext.. |
| 252.54 Mio. EUR |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| - |
| ADLAI NORTYE |
| 05.04.26 |
|